CD4+/DC25+T-lymphocytes and Th1/Th2 regulation in dilated cardiomyopahy

Hippokratia

Volumn 15, Issue 4, 2011, Pages 335-342

  Efthimiadis, I ^a   Skendros, P ^a   Sarantopoulos, A ^a   Boura, P ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

CD4+ CD25+T lymphocytes; Cytokines; Dilated cardiomyopathy; Th1 Th2 regulation

Indexed keywords

CARDIAC MYOSIN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR;

ADULT; ARTICLE; CD25+ T LYMPHOCYTE; CHRONIC DISEASE; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EX VIVO STUDY; FEMALE; FLOW CYTOMETRY; FLUORESCENCE; HEART VENTRICLE HYPERTROPHY; HUMAN; IMMUNE RESPONSE; MALE; PATHOGENESIS; REGULATORY MECHANISM; SUPERNATANT; TH1 CELL; TH2 CELL;

EID: 80053456244     PISSN: 11084189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Izumi T, Takehana H, Matsuda C, Yokohama H, Kohno K, Suzuki K, et al. Experimental Autoimmune Myocarditis and Its Pathomechanism. Herz. 2000; 274-278.
2. Cunningham MW. Cardiac Myosin and the TH1/TH2 Paradigm in Autoimmune Myocarditis. AJP July. 2001; 159: 5-12.
3. Maisch B, Richter A, Sandmöller A, Portig I, Pankuweit S. Inflammatory dilated cardiomyopathy (DCMI). Herz. 2005; 30: 535-544.
4. Kallwellis-Opara A, Dorner A, Poller WC, Noutsias M, Kóhl U, Schultheiss HP, et al. Autoimmunological features in inflammatory cardiomyopathy. Clin Res Cardiol. 2007; 96: 469-480.
5. Lindner J, Noutsias M, Lassner D, Wenzel J, Schultheiss HP, Kuehl U, et al. Adaptive immune responses against parvovirus B19 in patients with myocardial disease. J Clin Virol. 2009; 44: 27-32.
6. Kaya Z, Katus HA. Role of autoimmunity in dilated cardiomyo- pathy. Basic Res Cardiol. 2010; 105: 7-8.
7. Elliott P, Andersson B, Arbustini E, Bilinska Z, Cecchi F, Charron P, et al. Classification of the cardiomyopathies: a position state- ment from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2008; 29: 270-276.
8. Izumi T, Kohno K, Inomata T, Takagaki Y. Myocardiotogenic epitopes and autoimmune myocarditis. Intern Med. 2003; 42: 3-6.
9. Cunningham MW. T cell mimicry in inflammatory heart disease. Mol Immunol. 2004; 40: 1121-1127.
10. rd ed. London: Elsevier; 2008.
11. Kurrer MO, Kopfb M, Penninger JM, Eriksson U. Cytokines that regulate autoimmune myocarditis. Swiss MED WKLY. 2002; 132: 408-413.
12. Yoshikawa and #x03A4;, Baba A, Nagatomo Y. Autoimmune Mechanisms Underlying Dilated Cardiomyopathy. Circ J. 2009; 73: 602-607.
13. rd edition. London: Academic Press; 1998.
14. McNamara DM, Holubkov R, Starling RC, Dec GW, Loh E, Torre-Amione G, et al. Controlled Trial of Intravenous Immune Globulin in Recent-Onset Dilated Cardiomyopathy. Circulation. 2001; 103: 2254-2259.
15. rd ed. New York: Oxford University Press; 2003.
16. rd ed. Philadelphia:WB Saun-ders; 2009.
17. Kodama M, Matsumoto Y, Fujiwara M, Masani F, Izumi T, Shi-bata A. A novel experimental model of Giant Cell Myocarditis induced in rats by immunization with cardiac myosin fraction. Clin Immunol Immunopathol. 1990; 57: 250-262.
18. rd ed. London: Mosby; 2008.
19. rd ed. London: Mosby; 2008.
20. Zhao P, Sharma AC, Ren J. Pathogenesis and therapy of auto-immunity-induced dilated cardiomyopathy. Front Biosci. 2009; 14: 1708-1715.
21. Limas CJ, Hasikidis C, Iakovou J, Kroupis C, Haidaroglou A, Cokkinos DV. Prognostic significance of soluble interleukin-2 receptor levels in patients with dilated cardiomyopathy. Eur J Clin Invest. 2003; 33: 443-448.
22. Bach JF. Infections and autoimmunity. Rev Med Interne. 2005; 26 Spec No 1: 32-4.
23. Jane-wit D, Tuohy VK. Autoimmune cardiac-specific T cell responses in dilated cardiomyopathy. Int J Cardiol. 2006; 112: 2-6.
24. Boura P, Lefkos N, Boudonas G, Kountouras J, Zacharioudaki E, Efthimiadis A, et al. Antigenic stimulation in T-cells cultures in cardiomyopathies: differences in cytokine profiles. Eur J Im-munogenet. 1999; 26: 285-291.
25. Noutsias M, Pauschinger M, Poller WC, Schultheiss HP, Kuhl U. Immunomodulatory treatment strategies in inflammatory car-diomyopathy: current status and future perspectives. Expert Rev Cardiovasc Ther. 2004; 2: 37-51.
26. Fukunaga T, Soejima H, Irie A, Sugamura K, Oe Y, Tanaka T, et al. Relation between CD4+ T-cell activation and severity of chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol. 2007; 100: 483-488.
27. Afanasyeva M, Georgakopoulos D, Belardi DF, Bedja D, Fair-weather D, Wang Y, et al. Impaired up-regulation of CD25 on CD4+ T cells in IFN-{gamma} knockout mice is associated with progression of myocarditis to heart failure. PNAS. 2005; 102: 180-185.
28. Fuse K, Kodama M, Aizawa Y, Yamaura M, Tanabe Y, Taka-hashi K, et al. Th1/Th2 Balance Alteration in the Clinical Course of a Patient With Acute Viral Myocarditis. Jpn Circ J. 2001; 65: 1082-1084.
29. Fuse K, Kodama M, Ito M, Okura Y, Kato K, Hanawa H, et al. Polarity of helper T cell subsets represents disease nature and clinical course of experimental autoimmune myocarditis in rats. Clin Exp Immunol. 2003; 134: 403-408.
30. Eriksson U, Kurrer MO, Sebald W, Brombacher F, Kopf M. Dual Role of the IL -12/IFN-γ Axis in the Development of Autoimmune Myocarditis: Induction by IL-12 and Protection by IFN-1. J Immunol. 2001; 167: 5464-5469.
31. Lindberg E, Andersson B, Hörnquist EH, Magnusson Y. Impaired activation of IFN-γ CD4+ T cells in peripheral blood of patients with dilated cardiomyopathy. Cell Immunol. 2010; 263: 224-229.
32. Li Y, Heuser JS, Kosanke SD, Hemric M, Cunningham MW. Protection against Experimental Autoimmune Myocarditis Is Mediated by Interleukin-10-Producing T Cells that Are Controlled by Dendritic Cells. AJP. 2005; 167: 5-15.
33. Mosser DM, Zhang X. Interleukin-10: new perspectives on an old cytokine. Immunol Rev. 2008; 226: 205-218.